Furthermore, mutations in tumor suppressor genes LRP1B, SETD2, and TP53 are strongly associated with larger tumor size, elevated ki67 expression, lymph node metastasis, and advanced pathological stage in patients with LUAD, implying a significant association with proliferation and metastasis of LUAD. Here, SETD2 is linked to neoplasm.